Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott ...
Tag: Pharmaceuticals
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically ...
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois, ...
Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growth
Pune-based Emcure Pharmaceuticals on Thursday reported a 41% year-on-year increase in first quarter net profit at Rs 215 crore.Revenue from ...
UnitedHealth says it is cooperating with DOJ investigations into Medicare billing practices
UnitedHealth Group revealed Thursday it is facing Department of Justice investigations over its Medicare billing practices, adding to a string ...
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.Shelby Knowles | Bloomberg | Getty ImagesFor well ...
Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals
An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The ...
RFK Jr.’s CDC vaccine panel will review long-approved shots as skeptics gain sway
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.Tami Chappell | ReutersHealth and ...
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the ...
